Lunai Bioworks Inc. Acquisitions, Net of Cash Acquired
Lunai Bioworks Inc. (LNAI) reported Acquisitions, Net of Cash Acquired of $294.93 thousand for the 12-month period ending 2018-06-30, per its 10-K filed 2019-09-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2019-09-30
- Lunai Bioworks Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2018-06-30 was $297.00K.
- Lunai Bioworks Inc. payments to acquire businesses, net of cash acquired for fiscal 2018 was $294.93K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|
| 2018-06-30 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30 | $294.93K 10-K · filed 2019-09-30 | |
| 2018-03-31 | -$2.07K 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |